Portsmouth NH 400th Inc. Announces Official Program Partner Application Process
January 26, 2022Portsmouth NH 400th, Inc. has finalized the application form for organizations planning events, projects and programs for the anniversary celebration in 2023 and invites those who are interested to submit their details. Once reviewed by the Portsmouth NH 400th, Inc. Management Team and assigned to one of the thematic Team Leaders, the Official Partner Programs will be listed on the PortsmouthNH400.org calendar and will be authorized to use the PNH400 Official Partner logo.
City of Portsmouth Promotes Christine Friese to Library Director
January 21, 2022City Manager Karen Conard is pleased to announce the promotion of Christine C. Friese to the position of Director of the Portsmouth Public Library, effective March 1, 2022.
City of Portsmouth Finance Department Publishes FY21 Popular and Annual Comprehensive Financial Reports
January 12, 2022The Portsmouth community can now access the Annual Comprehensive Financial Report and the Popular Annual Financial Report (PAFR) for Fiscal Year 2021 (FY21) on the City of Portsmouth website. The City of Portsmouth prepares the two documents following the close of each fiscal year under the guidance of Director of Finance and Administration Judie Belanger.
City Warming Centers Counter Frigid Cold Tues Jan 11
January 10, 2022The City invites residents to come in out of the cold weather on Tues Jan 11 at two facilities. The Senior Activity Center (125 Cottage St.) is open 9 am to 5 pm. The Portsmouth Public Library is open 9 am to 9 pm. Both facilities require visitors to wear face-coverings while indoors.
City of Portsmouth Plans Inauguration Outside on January 3, 2022
December 29, 2021Out of an abundance of caution against the spread of the highly infectious Omicron variant of COVID-19, the Mayor-elect has determined that the Inauguration for the City Council, Police Commission, Fire Commission and School Board will be held outdoors on Monday, January 3, 2022. The abbreviated ceremony will take place at the 9/11 Memorial in the upper parking lot at City Hall, starting at 7 pm.
Portsmouth NH 400th Holds First Task Force Meeting, Opens Fund-raising Portal
December 29, 2021The Portsmouth NH 400th Executive Team held an organizational meeting of the Portsmouth NH 400th Task Force on September 2, 2021 and is forming sub-committee teams to begin planning for the city’s celebration in 2023. The Task Force is designed to support the Portsmouth NH 400th organization and guide signature events and projects, including a parade.
The Executive Team now includes:
Holiday Lights Contest Winners Announced
December 22, 2021Once again the Neighborhood Holiday Lights Contest received enthusiastic support, with 48 Portsmouth residents participating. Mayor Rick Becksted joined members of the Citywide Neighborhood Committee and the children who did the judging to announce the winners at the City Council meeting on Monday, December 20. Winners will receive their gift cards in a letter from the Mayor.
Parking Holiday Dec 18-25, 2021
December 17, 2021Parking payment for on-street and lot spaces managed by the City of Portsmouth is not enforced on these dates. This parking holiday does not apply to parking in the Hanover and Foundry garages.
Foundation for Seacoast Health Announces Potential Plan to Sell Community Campus to City
December 16, 2021The Foundation for Seacoast Health has announced their intent to sell the Community Campus building and surrounding 34 acres to the City of Portsmouth. Following a three-year strategic planning process and a goal to maintain its original vision as a multi-tenant non-profit center, while adding new resources to benefit the community, the Foundation has determined the City to be the ideal buyer to manage the Campus.
Evusheld Treatment
December 16, 2021What is the “Evusheld” treatment and how does it work?
Evusheld is a pre-COVID protection option developed by AstraZeneca that combines two monoclonal antibodies (tixagevimab and cilgavimab) in one injection. In a study of persons who were at high risk of severe illness, hospitalization, or death from COVID-19 because they were immunocompromised or ineligible to receive a COVID-19 vaccination, Evusheld was shown to reduce the risk of developing COVID-19 compared to those who received a placebo.